Taken together, this observation indicates an interaction between HA and the tumor immune microenvironment, and provides a potential explanation why tumors in the TAP ≥ 5%, HA + subgroup did not respond to PD-1 therapy despite being PD-L1 positive. Here, PDCD1 is linked to neoplasm.